The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Covid-19 and Morocco Pilot Trial

16 Mar 2020 07:00

RNS Number : 1855G
Quadrise Fuels International PLC
16 March 2020
 

16 March 2020

 

 

Quadrise Fuels International plc

("Quadrise", "QFI", the "Company" and together with its subsidiaries the "Group")

 

Statement re Covid-19

 

Morocco Pilot Trial Schedule

 

Having implemented a plan to protect the Group's employees and business as a pre-emptive, pragmatic and measured approach to prevailing global events, the Company provides the following update.

 

The Company confirms that its London office remains open, that the Quadrise Research Facility ("QRF") in Essex remains operational and that the Company continues with its business development activities where permitted to do so, including a team of three QFI personnel visiting South America during week commencing 9 March 2020 alongside Freepoint representatives, for a positive follow-up meeting which included a visit to a refinery and nearby powerplant.

 

To seek to ensure that this remains the case, no third-party visitors are being accepted at QRF and the Company has put in place appropriate measures to, inter alia, ensure that London based staff will, in the main be working remotely, with little, if any, impact on their normal activities but minimising the potential risk to the Group's employees.

 

Notwithstanding the above, the Company announces that it has now been informed that the MSAR® pilot trial in Morocco will be delayed, as the client is now restricting site access for external contractors, as a precaution not dissimilar to the Company's own approach in relation to the QRF.

 

No revised trial schedule has yet been indicated and further announcements in relation to the situation in Morocco and the revised trial schedule, will be made, as appropriate in due course. All of the equipment required for the trial is now in Morocco including the MSAR® fuel produced at QRF, enabling the trial to commence as soon as the site can again be accessed by QFI.

 

Mike Kirk, Chairman of QFI, said:

 

"We have taken a pragmatic approach to the rapidly developing global Covid-19 situation and taken actions to protect our staff and the business which we believe will be effective in the short to medium term. The decision by our client in Morocco to delay the pilot trial is not surprising and parallels the procedures we have put in place to protect QRF. With all of the equipment and fuel for the trial now in Morocco, we will be in a position to commence the trial very rapidly, once we are able to access the client's site.

 

In the meantime, we will continue to progress with business development activities in line with any restrictions that may be in place. The visit by our team to South America last week shows that we can still respond positively and actively to opportunities as they arise, and we have the capability to progress discussions and technical and economic analysis via web/videoconferencing with clients if face to face meetings are not possible."

 

For additional information, please contact:

 

Quadrise Fuels International plc +44 (0)20 7031 7321

Mike Kirk, Chairman

Jason Miles, Chief Operating Officer

 

Cenkos Securities plc +44 (0)20 7397 8900

Nominated Adviser

Ben Jeynes

Katy Birkin

 

Peel Hunt LLP +44 (0)20 7418 8900

Joint Broker

Richard Crichton

David McKeown

 

Shore Capital Stockbrokers Limited +44 (0)20 7408 4090

Joint Broker

Toby Gibbs

Fiona Conroy

 

FTI Consulting +44 (0)20 3727 1000

Public and Investor Relations

Ben Brewerton

Ntobeko Chidavaenzi

 

The information communicated within this announcement was deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 prior to the release of this announcement. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRFZGMFZKRGGZM
Date   Source Headline
13th Mar 20237:00 amRNSProposed Change of Name
6th Mar 20234:35 pmRNSPrice Monitoring Extension
3rd Mar 20237:00 amRNSWärtsilä Testing Update
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
23rd Feb 20237:00 amRNSMorocco Project Update
1st Feb 20237:00 amRNSBlock Admission Cancellation and Interim Review
31st Jan 20237:00 amRNSAppointment of New Auditor
30th Jan 20237:00 amRNSRe-Issue of Historical Share Options
16th Jan 20237:00 amRNSBusiness Update
29th Nov 20222:23 pmEQSQuadrise Fuels International (QFI): Key role in transitioning to net-zero
25th Nov 20222:16 pmRNSResult of AGM
25th Nov 20227:00 amRNSAGM Statement
23rd Nov 20227:00 amRNSPublication of Sustainability Report
15th Nov 20227:00 amRNSExtension of Exclusive Agreement with Nouryon
28th Oct 20224:48 pmRNSPosting of Annual Report and Notice of AGM
3rd Oct 20227:00 amRNSFinal Results and Notice of AGM
21st Sep 20227:00 amRNSJoint Development Agreement with Vertoro
14th Sep 20227:00 amRNSNotice of Results and Investor Presentation
4th Aug 20227:00 amRNSIssue of Share Options and Director/PDMR Dealing
1st Aug 202210:52 amRNSDirector/PDMR Dealing
1st Aug 20229:30 amRNSBlock Admission Interim Review
27th Jul 20227:00 amRNSFramework Agreement with MSC Shipmanagement
21st Jul 20224:41 pmRNSSecond Price Monitoring Extn
21st Jul 20224:35 pmRNSPrice Monitoring Extension
15th Jul 20225:40 pmRNSHolding(s) in Company
16th Jun 20227:00 amRNSIssue of Warrants
13th Jun 20227:30 amRNSMaterial Transfer & Cooperation Agreement
13th Jun 20227:00 amRNSAddendum to Representation Agreement
9th May 20227:00 amRNSOperational Update
22nd Apr 20224:40 pmRNSSecond Price Monitoring Extn
22nd Apr 20224:35 pmRNSPrice Monitoring Extension
11th Apr 20224:41 pmRNSSecond Price Monitoring Extn
11th Apr 20224:35 pmRNSPrice Monitoring Extension
11th Apr 20228:28 amRNSCommercial Development Agreement with Valkor
28th Mar 20227:00 amRNSInterim Results
1st Feb 20223:00 pmRNSBlock Admission Interim Review
1st Feb 20228:44 amRNSReplacement:Appointment of Non-Executive Chairman
1st Feb 20227:00 amRNSAppointment of Non-Executive Chairman
31st Jan 20227:00 amRNSUpdate re bioMSAR Testing at Aquafuel Research Ltd
27th Jan 202211:57 amRNSHolding(s) in Company
17th Jan 20224:41 pmRNSSecond Price Monitoring Extn
17th Jan 20224:35 pmRNSPrice Monitoring Extension
6th Jan 20224:41 pmRNSSecond Price Monitoring Extn
6th Jan 20224:36 pmRNSPrice Monitoring Extension
4th Jan 20227:00 amRNSAppointment of Chief Operating Officer
29th Dec 20214:42 pmRNSSecond Price Monitoring Extn
29th Dec 20214:36 pmRNSPrice Monitoring Extension
21st Dec 20214:41 pmRNSSecond Price Monitoring Extn
21st Dec 20214:36 pmRNSPrice Monitoring Extension
15th Dec 20215:05 pmRNSChange of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.